Germany: Amboss secures €240m to fund investment in technology and new market segments
Germany-based Amboss, a medical knowledge and learning platform, has secured €240m (US$260m) in a financing round to help expands its position as the leading...
Switzerland: Alcon agrees acquisition of Lensar for up to US$430m
SIX-Swiss listed Alcon, the largest eye care device company in the world, is acquiring Nasdaq-listed Lensar, a global medical technology company focused on advanced...
Belgium: Augustine Therapeutics completes €77.7m Series A
Augustine Therapeutics has completed a €77.7m (US$84.8m) Series A financing round co-led by Novo Holdings and Jeito Capital, supported by existing investors Asabys Partners,...
UK: Thena Capital launches Fund I with first close of £27m
Thena Capital, a UK-based early-stage medical technology investor, has launched its Fund I with a first close at £27m (US$35m) of its £50m target.
The...
Germany: Mérieux Equity Partners acquires majority stake in curea medical
France-based European healthcare-specialized investment firm Mérieux Equity Partners (MxEP) has acquired a majority stake in curea medical, a carve-out from McAirlaid’s. The investment aims...
UK: Brainomix completes Series C funding round as it accelerates into US
Brainomix, a company pioneering AI-powered imaging tools in stroke and lung fibrosis, has completion a £14m (US$18m) Series C investment round co-led by Parkwalk...
Sweden: Raysearch founder raises SEK500m from sale of company shares
Johan Löf, CEO and founder of Sweden-based medtech company Raysearch Laboratories has sold 2 million class B shares, corresponding to 5.8% of the company’s...
UK: Pfizer raises £2.5bn from disposal of last holding in Haleon
UK pharma, Pfizer, has received gross proceeds of approximately £2.5bn (US$3.3bn) from the sale of its entire remaining shareholding in British healthcare company, Haleon, of...
UK: SV Health Investors’ Dementia Discovery Fund 2 (DDF-2) secures £25m commitment from British Patient Capital
British Patient Capital, a commercial subsidiary of the British Business Bank, has made a £25m (US$32m) commitment to the Dementia Discovery Fund 2 (DDF-2),...
UK: Maxion Therapeutics raises US$72m in Series A financing
Maxion Therapeutics, a biotech company developing antibody-based ‘KnotBody’ drugs for ion channel- and G protein coupled receptor (GPCR)-driven diseases, has raised US$72m (£58m) in...
Advertisement
